D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 17 520 KRW 7.03%
Market Cap: 770.2B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Dongkook Pharmaceutical Co Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dongkook Pharmaceutical Co Ltd
Net Income Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Net Income
â‚©55.3B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
12%
Yuhan Corp
KRX:000100
Net Income
â‚©145.9B
CAGR 3-Years
16%
CAGR 5-Years
28%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Net Income
-â‚©35.4B
CAGR 3-Years
48%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Net Income
â‚©207.2B
CAGR 3-Years
87%
CAGR 5-Years
35%
CAGR 10-Years
15%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Net Income
â‚©723.7m
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
-24%
C
Celltrion Pharm Inc
KOSDAQ:068760
Net Income
â‚©11.5B
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
8%

See Also

What is Dongkook Pharmaceutical Co Ltd's Net Income?
Net Income
55.3B KRW

Based on the financial report for Jun 30, 2024, Dongkook Pharmaceutical Co Ltd's Net Income amounts to 55.3B KRW.

What is Dongkook Pharmaceutical Co Ltd's Net Income growth rate?
Net Income CAGR 10Y
12%

Over the last year, the Net Income growth was 12%. The average annual Net Income growth rates for Dongkook Pharmaceutical Co Ltd have been 1% over the past three years , 1% over the past five years , and 12% over the past ten years .

Back to Top